CRLBF Cresco Labs, Inc.
- 0.933
- -0.016-1.70%
Cresco Labs, Inc. News
Haywood Maintains Cresco Labs, Inc.(CRLBF.US) With Buy Rating, Cuts Target Price to $2.01
Cormark Securities Downgrades Cresco Labs, Inc.(CRLBF.US) to Hold Rating, Cuts Target Price to $1.97
Haywood Maintains Cresco Labs, Inc.(CRLBF.US) With Buy Rating, Maintains Target Price $2.91
Cresco Labs Analyst Ratings
Needham Maintains Cresco Labs, Inc.(CRLBF.US) With Hold Rating
Haywood Maintains Cresco Labs, Inc.(CRLBF.US) With Buy Rating, Cuts Target Price to $2.88
Cresco Labs Analyst Ratings
Cresco Labs Analyst Ratings
Cresco Labs Analyst Ratings
Wedbush Maintains Outperform on Cresco Labs, Lowers Price Target to $2
Cresco Labs Analyst Ratings
Cantor Fitzgerald Maintains Overweight on Cresco Labs, Maintains $14.25 Price Target
Cresco Labs Analyst Ratings
Cresco Labs Analyst Ratings
Cowen & Co. Downgrades Cresco Labs to Market Perform, Lowers Price Target to $2.5
Cresco Labs Analyst Ratings
Wedbush Initiates Coverage On Cresco Labs With Outperform Rating, Announces Price Target of $4.5
Cantor Fitzgerald Cuts Price Target On This Cannabis MSO, But Touts Its Operations As 'One Of Best-In-Class'
Piper Sandler Maintains Overweight on Cresco Labs, Lowers Price Target to $6
Cantor Fitzgerald Maintains Overweight on Cresco Labs, Lowers Price Target to $15
No Data